Lurasidone Market size is estimated to be USD 1.2 Billion in 2024 and is expected to reach USD 2.5 Billion by 2033 at a CAGR of 9.1% from 2026 to 2033.
The Asia Pacific Lurasidone Market Is Experiencing Significant Growth, Driven By The Rising Demand For Medications Used To Treat Psychiatric Disorders Such As Schizophrenia And Bipolar Disorder. Lurasidone, A Second-Generation Antipsychotic, Has Been Gaining Popularity Due To Its Ability To Provide Effective Relief With Fewer Side Effects Compared To Traditional Antipsychotics. As The Region Grapples With Increasing Mental Health Challenges, The Need For Innovative And Reliable Pharmaceutical Treatments Has Never Been More Pronounced.
Industries In The Healthcare Sector Are Particularly Keen On Lurasidone Due To Its Favorable Safety Profile. Pharmaceutical Companies Are Expanding Their Production To Meet The Growing Demand, Particularly In Countries With Large Populations Such As China, India, And Japan. The Increasing Awareness Of Mental Health Conditions And A Greater Focus On Mental Well-Being Have Also Driven The Market'S Expansion. As Of Now, Key Players In The Market Are Actively Exploring Distribution Channels To Increase The Accessibility Of Lurasidone-Based Treatments In The Region.
One Of The Key Requirements From Industries Is The Need For Efficient Drug Manufacturing Processes. This Includes The Production Of High-Quality Lurasidone At A Scale That Can Meet Both Domestic And International Demand. The Regulatory Environment Plays A Critical Role In Ensuring That Drugs Are Produced According To The Highest Standards. In Addition To Manufacturing Capabilities, The Market Is Also Seeing A Demand For Faster Drug Delivery Systems, As Patients Seek More Convenient Treatment Options. This Has Led To The Development Of Extended-Release Formulations, Which Offer A Longer Therapeutic Effect With Fewer Doses Per Day.
Another Essential Requirement Is The Growing Demand For Cost-Effective Solutions In The Healthcare System. Many Countries In The Asia Pacific Region Face Economic Challenges, And The Affordability Of Medications Like Lurasidone Is Critical In Driving Widespread Adoption. Governments And Healthcare Providers Are Working Together To Ensure That Psychiatric Drugs Are Accessible To Underserved Populations While Maintaining The Quality Of Care.
With The Increasing Demand And Evolving Needs Of The Healthcare Industry, The Lurasidone Market In The Asia Pacific Region Is Set To Continue Its Upward Trajectory. Ongoing Research Into Improving Formulations And Exploring New Treatment Combinations Will Further Enhance The Market’S Prospects, Benefiting Both Patients And The Industries That Support Mental Health Care.
Get an In-Depth Research Analysis of the Asia Pacific Lurasidone Market Size And Forecast [2025-2032]
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co.
Ltd.
RemedyRepack，Inc.
Bushu Pharmaceutical
LTD.
Zhejiang Hisun Pharmaceutical Co.
Ltd.
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
By 2030, Asia Pacific is expected to witness significant momentum in the market research industry, aligning with the global projection of surpassing $120 billion, driven by a compound annual growth rate (CAGR) of over 5.8% from 2023 to 2030. The industry in Asia Pacific is being reshaped by technological disruptions, particularly through the adoption of machine learning, artificial intelligence, and advanced data analytics. These technologies provide businesses with predictive analysis and real-time consumer insights, enabling smarter and more precise decision-making. As part of the broader Asia-Pacific region, Asia Pacific is positioned to contribute substantially to the over 35% revenue growth expected from this region. Additionally, the adoption of innovative techniques such as mobile surveys, social listening, and online panels is rapidly gaining ground in Asia Pacific, emphasizing speed, precision, and customization, and driving a new era of data-driven strategies across industries.
Get Discount On The Purchase of the Asia Pacific Lurasidone Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Asia Pacific Lurasidone Market
Tablets
Oral Suspension
Intramuscular Injection
Schizophrenia
Bipolar Depression
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Children and Adolescents
Adults
Elderly
Male
Female
Short-term Treatment
Long-term Maintenance Therapy
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Asia Pacific Lurasidone Market Research Analysis
1. Introduction of the Asia Pacific Lurasidone Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Asia Pacific Lurasidone Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Asia Pacific Lurasidone Market, By Type
6. Asia Pacific Lurasidone Market, By Application
7. Asia Pacific Lurasidone Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Asia Pacific
Vietnam
8. Asia Pacific Lurasidone Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/